Neck phlegmon in COVID-19 patients

Arkadiusz Trybek; Piotr Lichota; Jacek Wilczynski; Rafał Zieliński

doi:10.5114/ms.2021.112392

eISSN: 2300-6722
ISSN: 1899-1874

Medical Studies/Studia Medyczne

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2021
vol. 37

Send email

Copy url:

abstract:

Case report

Neck phlegmon in COVID-19 patients

Arkadiusz Trybek

¹

,

Piotr Lichota

¹

,

Jacek Wilczynski

²

,

Rafał Zieliński

^{1, 2}

Department of Otorhinolaryngology, Provincial Polyclinic Hospital, Kielce, Poland
Collegium Medicum, Jan Kochanowski University, Kielce, Poland

Medical Studies/Studia Medyczne 2021; 37 (4): 349–353

DOI: https://doi.org/10.5114/ms.2021.112392

Online publish date: 2021/12/31

View full text Get citation

PlumX metrics:

Reports on patients hospitalised due to inflammatory diseases of the soft tissues in the head suggest worsening of the course of the underlying disease in the case of coexisting infection with the SARS-CoV-2 virus. The cases of 2 patients with neck phlegmon in the course of Coronavirus disease 19 (COVID-19) hospitalised at our Otorhinolaryngological Unit have been presented in the paper. Despite intensive treatment, the disease was fatal in both cases. COVID-19 probably has a significant impact on the course of disease and treatment results in the cases of patients with neck phlegmon. Coexisting diseases may seriously worsen the prognosis in patients with neck phlegmon and COVID-19. Further research is required to explain the mechanism of the impact of SARS-CoV-2 infection on the course of phlegmon in the head and neck region.

keywords:

Neck phlegmon in COVID-19 patients

Arkadiusz Trybek 1 , Piotr Lichota 1 , Jacek Wilczynski 2 , Rafał Zieliński 1, 2

phlegmon, neck, SARS-CoV-2, COVID-19

Arkadiusz Trybek

¹

,

Piotr Lichota

¹

,

Jacek Wilczynski

²

,

Rafał Zieliński

^{1, 2}